Related Experiment Video

Updated: Jun 9, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Practice and child characteristics associated with influenza vaccine uptake in young children

Katherine A Poehling1, Gerry Fairbrother, Yuwei Zhu

  • 1Wake Forest University Medical Center, Department of Pediatrics, Winston-Salem, NC 27157, USA. kpoehlin@wfubmc.edu

Pediatrics
|September 8, 2010
PubMed

Insights

Pediatric influenza vaccination coverage in 2004-2005 was 27%. Key strategies for increasing childhood flu shots included evening/weekend vaccine clinics and scheduling visits between October and January.

Area of Science:

  • Pediatrics
  • Public Health
  • Vaccinology

Background:

  • The 2004-2005 influenza season marked the first year of universal influenza vaccination recommendations for children aged 6 to 23 months.
  • Understanding factors influencing vaccine uptake is crucial for improving childhood immunization rates.

Purpose of the Study:

  • To identify practice and child characteristics associated with influenza vaccine receipt in young children.
  • To evaluate practice strategies that may enhance influenza vaccination coverage.

Main Methods:

  • A community-based cohort study involved chart reviews of 2384 children aged 6 to 23 months across 3 US counties.
  • Practices completed surveys to assess their characteristics and vaccination strategies.
  • Multinomial logistic regression was used to determine predictors of complete influenza vaccination.

Main Results:

  • Overall, 27% of eligible children received the influenza vaccine.
  • Vaccination rates varied significantly among practices, ranging from 0% to 71%.
  • Factors associated with higher vaccination rates included suburban practice location, lower patient volume, evening/weekend vaccine clinics, younger child age, presence of high-risk conditions, multiple well visits, and visits between October and January.

Conclusions:

  • Modifiable practice-level factors, such as offering evening/weekend vaccine clinics and scheduling visits from October to January, are associated with increased influenza vaccination coverage in young children.
  • Targeted strategies can help improve adherence to universal childhood influenza vaccination recommendations.
Abstract

More Related Videos

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

Assessing Respiratory Immune Responses to Haemophilus Influenzae06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...